Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
    • Journal Club
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Respiratory & Allergy
  4. COPD
  5. Treatment

Treatment

  • Allergic Reactions (134)
  • Allergic Rhinitis (58)
  • Asthma (167)
  • Autoimmune Disorders (3)
  • COPD (144)
    • Immunizations (39)
    • Interactions (11)
    • Treatment (118)
  • Cystic Fibrosis (4)
  • Ear Health (13)
  • Ear, Nose & Throat (37)
  • E-Cigarettes (1)
  • Immunology (5)
  • Inhalers (31)
  • Other (16)
  • Otolaryngology (22)
  • Pulmonary (24)
  • Resources (291)
  • Respiratory Infections (431)
  • Sleep Apnea (14)
  • Smoking (22)
  • Smoking Cessation (122)
61 - 75 of 118 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Tudorza Pressair (Aclidinium) December 2012
Commentary: Safety of Long-Acting Beta-Agonists in Asthma November 2012
Commentary: New Formulation: Combivent Respimat September 2012
Article: Combivent Respimat (ipratropium/albuterol) September 2012
Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease UPDATED 2010 January 2012
Commentary: New Drug: Arcapta (Indacaterol) January 2012
Article: Arcapta (ar-CAP-ta), a new inhaled long-acting beta-agonist for COPD January 2012
Article: You'll finally see Primatene Mist (epinephrine) disappear and the new Combivent Respimat appear November 2011
Commentary: Market Withdrawal of Primatene Mist (Epinephrine) Inhalers November 2011
Other: FDA Podcast: Withdrawal of Primatene Mist (April 2011) November 2011
Article: chronic azithromycin to PREVENT recurrent COPD exacerbations October 2011
Commentary: Azithromycin to Prevent COPD Exacerbations October 2011
Commentary: Spiriva (Tiotropium) vs Long-Acting Beta-2 Agonists for COPD August 2011
Article: Daliresp (DA-li-resp), a new oral tablet for severe COPD in patients with chronic bronchitis July 2011
Commentary: New Drug: Daliresp (Roflumilast) July 2011
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved